Jennison Associates’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.5M | Buy |
1,399,299
+273,579
| +24% | +$8.89M | 0.03% | 233 |
|
|
2025
Q1 | $42.5M | Sell |
1,125,720
-120,831
| -10% | -$4.56M | 0.03% | 234 |
|
|
2024
Q4 | $102M | Buy |
1,246,551
+9,121
| +0.7% | +$747K | 0.06% | 141 |
|
|
2024
Q3 | $141M | Sell |
1,237,430
-145,701
| -11% | -$16.6M | 0.09% | 95 |
|
|
2024
Q2 | $104M | Buy |
1,383,131
+126,248
| +10% | +$9.53M | 0.07% | 120 |
|
|
2024
Q1 | $85.9M | Sell |
1,256,883
-219,271
| -15% | -$15M | 0.06% | 136 |
|
|
2023
Q4 | $92.7M | Sell |
1,476,154
-278,537
| -16% | -$17.5M | 0.07% | 122 |
|
|
2023
Q3 | $89.5M | Buy |
1,754,691
+300,189
| +21% | +$15.3M | 0.08% | 118 |
|
|
2023
Q2 | $72.6M | Buy |
1,454,502
+24,463
| +2% | +$1.22M | 0.06% | 144 |
|
|
2023
Q1 | $53.6M | Buy |
1,430,039
+8,032
| +0.6% | +$301K | 0.05% | 175 |
|
|
2022
Q4 | $68.2M | Buy |
+1,422,007
| New | +$68.2M | 0.07% | 151 |
|